Insulin aspart, recombinant Subcutaneous and Pitavastatin
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pitavastatin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pitavastatin
Brand name: Livalo, Zypitamag
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Pitavastatin Calcium, Pitavastatin Magnesium
- Insulin aspart, recombinant Subcutaneous-Pitocin
- Insulin aspart, recombinant Subcutaneous-Pitolisant
- Insulin aspart, recombinant Subcutaneous-Pitolisant Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Pitressin
- Insulin aspart, recombinant Subcutaneous-Pitressin Injection
- Pitavastatin-Insulin degludec
- Pitavastatin-Insulin Degludec (U-100) Prefilled Pens
- Pitavastatin-Insulin Degludec (U-100) Vials
- Pitavastatin-Insulin Degludec (U-200) Prefilled Pens
- Pitavastatin-Insulin degludec and liraglutide
- Pitavastatin-Insulin degludec and liraglutide Subcutaneous